VI

View company's website

San Diego, US · 1 known investors

replicatebioscience.com ↗

Replicate Bioscience develops self-replicating RNA (srRNA) vector platform technology for therapeutic treatments across infectious disease, oncology, and autoimmune disorders. The company's approach leverages srRNA to drive repeated production of natural RNA within cells, enabling sustained protein expression and therapeutic effects.

Investors · 1

AP

Apple Tree Venture Management LlcNew York